← SynDRA
DPI-201-106
SynDRA canonical compound SYN1953358 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | ADRB2 |
| Mechanism of action | sodium channel activator |
All known targets
Mechanisms of action (all sources)
- sodium channel activator
- ADRB2 INHIBITOR
Cross-references
Synonyms
- Dpi 201-106
- 4-{3-[4-(Diphenylmethyl)piperazin-1-yl]-2-hydroxypropoxy}-1h-indole-2-carbonitrile
- SDZ-201106
- CHEMBL314639
- SDZ-201 106 (+/-)
- (+-)-4-(3-(4-(Diphenylmethyl)-1-piperazinyl)-2-hydroxypropoxy)-1H-indole-2-carbonitrile
- 1H-Indole-2-carbonitrile, 4-(3-(4-(diphenylmethyl)-1-piperazinyl)-2-hydroxypropoxy-, (+-)-
- 4(3-(4-Diphenylmethylpiperazine-1-yl)-2-hydroxypropoxy)-1H-indol-2-carbonitrile
- CBiol_001886
- DPI-201106
- 4-(3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropoxy)-1H-indole-2-carbonitrile
Look up DPI-201-106 in the interactive SynDRA portal →